Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,436
Closed -$25K 3658
2025
Q3
$25K Buy
+15,436
New +$32.3K ﹤0.01% 2682
2024
Q1
Sell
-12,144
Closed -$154K 2753
2023
Q4
$154K Buy
12,144
+1,952
+19% +$20.3K ﹤0.01% 1836
2023
Q3
$105K Sell
10,192
-86,503
-89% -$1M ﹤0.01% 1942
2023
Q2
$1.27M Buy
+96,695
New +$1.18M 0.01% 806
2023
Q1
Sell
-64,767
Closed -$545K 2887
2022
Q4
$545K Buy
+64,767
New +$616K 0.01% 1349

Other funds holding LUNG

HRT Financial's LUNG Position: Q4 2025 in Review

HRT Financial sold out of Pulmonx (LUNG) in Q4 2025, closing a stake of 15,436 shares — an estimated $25K sold.

HRT Financial first reported a position in LUNG in Q4 2022 and held it in 5 quarters. The position peaked at $1.27M in Q2 2023. 112 funds tracked by Wall St. Rank hold LUNG as of Q4 2025.

  • HRT Financial reported no remaining Pulmonx position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 15,436 Pulmonx shares in Q4 2025, an estimated $25K.
  • HRT Financial first reported a position in Pulmonx in Q4 2022 and held it in 5 quarters.
  • HRT Financial's Pulmonx position peaked at $1.27M in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Pulmonx as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.